Hepatitis B reactivation after oral capecitabine treatment in a rectum cancer patient with isolated anti-HBc IgG positivity

dc.date.accessioned	2023-03-06T07:32:02Z
dc.date.available	2023-03-06T07:32:02Z
dc.date.issued	2022
dc.identifier.citation	J Oncol Pharm Pract. 2022 Jan 18:10781552221074627. doi: 10.1177/10781552221074627. Online ahead of print.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100131
dc.relation.isversionof	10.1177/10781552221074627
dc.relation.isversionof	10.1177/10781552221074627
dc.title	Hepatitis B reactivation after oral capecitabine treatment in a rectum cancer patient with isolated anti-HBc IgG positivity
dc.relation.journal	J Oncol Pharm Pract
dc.identifier.doi	10.1177/10781552221074627
dc.contributor.author	Tozlu M
dc.contributor.author	Tozlu M
dc.contributor.author	Toka B
dc.contributor.author	Eminler AT
dc.contributor.author	Karacaer C
dc.contributor.author	Hacibekiroglu I
dc.contributor.author	Uslan MI
dc.contributor.author	Koksal AS.